As demand for weight-loss drugs rises, states grapple with Medicaid coverage In January, the National Association of Medicaid Directors told the federal Centers for Medicare & Medicaid Services that state Medicaid departments had significant concerns over the fiscal impacts of the Biden proposal to require coverage of GLP-1s, and strongly recommend that CMS maintain the current state option to cover or not cover anti-obesity medications. But others say covering the drugs will yield long-term savings
Different NDC numbers, different indication codes, different formulary placement
Once dissolved, GSH is in an aqueous environment where oxidation proceeds continuously
One of the most profound mechanisms by which magnesium glycinate supports the neurologically compromised patient is through its interaction with the N-methyl-D-aspartate (NMDA) receptor
Eli Lilly told the firm it is not interested in exclusive "one-of-one" deals with PBMs, while Novo Nordisk said CVS approached the drugmaker about the Wegovy agreement, according to Seigerman
Why Bariatric Surgery Is Often More Insurable in California While coverage for weight loss drugs is shrinking, bariatric surgery remains a covered benefit under many California insurance plans, including Medi-Cal and employer-sponsored coverage
